Lindbrook Capital, LLC Heron Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$2.32 - $3.86 $37 - $61	16 New	16 $0
Q4 2022 Jan 24, 2023	BUY	$2.25 - $4.67 $1,167 - $2,423	519 Added 752.17%	588 $0
Q3 2022 Nov 10, 2022	SELL	$2.66 - $5.37 $10 - $21	-4 Reduced 5.48%	69 $0
Q2 2022 Aug 01, 2022	BUY	$2.3 - $6.29 $167 - $459	73 New	73 $0
Q3 2020 Nov 03, 2020	SELL	$13.67 - $17.77 $10,908 - $14,180	-798 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$10.89 - $21.47 $8,690 - $17,133	798 New	798 $12,000
Q1 2020 Apr 22, 2020	SELL	$10.23 - $24.56 $5,115 - $12,280	-500 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$17.42 - $26.61 $8,710 - $13,305	500 New	500 $12,000
Q3 2019 Oct 31, 2019	SELL	$16.36 - $21.39 $32,720 - $42,780	-2,000 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$16.93 - $26.22 $33,860 - $52,440	2,000 New	2,000 $37,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.